The Journal of Practical Medicine >
Effects of Busheng Huayu Qianggu prescription in elderly patients with osteoporotic lumbar fracture of kidney deficiency and blood stasis type
Received date: 2023-08-14
Online published: 2024-01-24
Objective To investigate the application value of Bushen Huayu Qianggu prescription in the treatment of senile osteoporotic lumbar fracture with kidney deficiency and blood stasis type. Methods All elderly patients with osteoporotic lumbar fractures of kidney deficiency and blood stasis were treated in our hospital from September 2021 to March 2023 and randomly divided into 68 cases in both groups. The control group was treated with conventional Western medicine, and the observation group was treated with BushengHuayuQiang Gu prescription for 12 weeks. Results Serum D-dimer (D-D), interleukin-6 (IL-6) and prostaglandin E2 (PGE2) were lower in the observation group than in the control group, and vascular endothelial growth factor (VEGF) and β-endorphin (β-EP) were higher (P < 0.05); serum osteoprotegerin (OPG) and bone morphogenetic protein-2 (BMP-2) were higher in the observation group (P < 0.05); total effective rate was as high as 95.59% (65%) (P < 0.05); bone mineral density (BMD) was higher in the observation group than in the control group after treatment, and the total symptom score and Cobb angle of Chinese medicine were lower (P < 0.05); the total effective rate of the observation group was as high as 95.59% (65/68), higher than that of the control groupwhich was 80.88%(55/68)(P < 0.05). Conclusion Combined treatment with BushenHuayuQianggu prescription can reduce inflammation, regulate bone metabolism, promote bone mineral density and improve clinical efficacy for senily-aged lumbar osteoporotic fracture caused by kidney deficiency and blood stasis.
Guodong QIU , Lei SUN , Shuihua. XIE . Effects of Busheng Huayu Qianggu prescription in elderly patients with osteoporotic lumbar fracture of kidney deficiency and blood stasis type[J]. The Journal of Practical Medicine, 2024 , 40(1) : 114 -118 . DOI: 10.3969/j.issn.1006-5725.2024.01.020
| 1 | WANG H, ZHANG L, DU H,et al. Efficacy and Safety Evaluation of Bilateral Pedicle Approach Combined with Positional Reduction for the Treatment of Osteoporotic Thoracolumbar Burst Fractures[J]. Altern Ther Health Med, 2023, 29(6):176-181. |
| 2 | LIU X F, WU H M.Re:Factors Affecting Delayed Union of Vertebral Fractures Following Percutaneous Kyphoplasty[J].Pain physician,2020,21(2):187-188. |
| 3 | MARUYAMA M, RHEE C, UTSUNOMIYA T,et al. Modulation of the Inflammatory Response and Bone Healing[J]. Front Endocrinol, 2020, 11:386. |
| 4 | LONG Y, YI W, YANG D. Advances in Vertebral Augmentation Systems for OsteoporoticVertebral Compression Fractures[J]. Pain Res Manag, 2020, 2020: 3947368. |
| 5 | 李跃华,颜明辉,吴世伟,等.骨质疏松症患者年龄、中医证型与腰椎压缩性骨折发生关系研究[J].北京中医药,2018,37(3):219-221. |
| 6 | 史晓林,刘康.骨质疏松性骨折中医诊疗指南[J].中国骨质疏松杂志,2022,9(5):1-16. |
| 7 | 郑筱萸. 中药新药临床指导原则 [S].北京:中国医药科技出版社,2002:162-167. |
| 8 | 李小海,谢光友,梁力嵩,等.贵州中老年人腰椎QCT骨密度及脊柱脆性骨折的骨密度分析[J].实用医学杂志,2023,39(1):60-65. |
| 9 | 郑伟杰,马航展,曾展鹏. 胸腰椎压缩性骨折复位床联合经皮椎体成形术治疗骨质疏松性椎体压缩性骨折的疗效[J]. 实用医学杂志, 2023,39(3):326-331. |
| 10 | 徐红辉,宋建东,李停,等. 骨质疏松性胸腰椎压缩性骨折患者血清过氧化物酶体增殖物激活受体γ辅激活因子1α、白介素-17表达水平及其与骨代谢的关系[J]. 中国医学前沿杂志(电子版), 2020,12(7):102-106. |
| 11 | SIMS N A. Influences of the IL-6 cytokine family on bone structure and function[J]. Cytokine, 2021, 146:155655. |
| 12 | WANG T, HE C. TNF-α and IL-6: The Link between Immune and Bone System[J]. Curr Drug Targets, 2020, 21(3):213-227. |
| 13 | NOGUCHI K, MAEDA M, RUWANPURA S M, et al. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells[J]. Oral Dis, 2005, 11(3):157-162. |
| 14 | TAKAYOSHI S, SHUNSUKE F, SOICHIRO M, et al. Clinical Features and Surgical Outcomes of Lower Lumbar Osteoporotic Vertebral Collapse with Symptomatic Stenosis: A Surgical Strategy from a Multicenter Case Series[J]. Asian Spine J, 2022, 16(6):906-917. |
| 15 | 李绍康,廖伟东,赵洁,等. 针刺对卒中恢复期相关性头痛患者血浆内源性阿片肽的影响[J]. 针刺研究, 2020, 45(12):995-999. |
| 16 | MEESON R, SANGHANI-KERI A, COATHUP M, et al. VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing[J]. J Orthop Res, 2019, 37(6):1294-1302. |
| 17 | CHANG C J, JOU I M, WU T T, et al. Cigarette smoke inhalation impairs angiogenesis in early bone healing processes and delays fracture union[J]. Bone Joint Res, 2020, 9(3):99-107. |
| 18 | CHOTIYARNWONG P, MCCLOSKEY E V. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment[J]. Nat Rev Endocrinol, 2020, 16(8):437-447. |
| 19 | UDAGAWA N, KOIDE M, NAKAMURA M,et al. Osteoclast differentiation by RANKL and OPG signaling pathways[J]. J Bone Miner Metab, 2021, 39(1):19-26. |
| 20 | PAJARINEN J, LIN T, GIBON E, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing[J]. Biomaterials, 2019, 196:80-89. |
| 21 | 庞大明,杨晋才,高海峰,等. 双侧经皮椎体后凸成形术对骨质疏松性椎体爆裂骨折的产生性及疗效评价[J]. 中华医学杂志, 2022, 102(35):2793-2798. |
| 22 | 白曼莫,王炳南,禹志军,等. 固脊通督方辅助治疗老年骨质疏松胸腰椎压缩性骨折疗效及对患者血清Leptin、PINP水平的影响[J]. 陕西中医, 2020,41(10):1449-1451. |
| 23 | 齐权律,黄超文,王晓晖,等. 补肾益精汤联合椎体后凸成形术治疗老年骨质疏松性胸腰椎压缩性骨折及对患者骨代谢指标的影响[J]. 中医临床研究, 2021,13(10):66-68. |
| 24 | 蒋维利,牛国旗,周功,等. 同步单侧穿刺经皮椎体后凸成形术治疗胸腰椎跳跃型双节段骨质疏松性椎体压缩骨折[J]. 中国修复重建外科杂志, 2021, 35(9):1155-1160. |
| 25 | 刘祎,徐海涛. 独活寄生汤联合PVP术治疗骨质疏松性胸腰椎骨折疗效及对骨代谢、椎体生理结构恢复的影响[J]. 四川中医, 2021,39(2):146-149. |
| 26 | 张武坤,范少勇. 益肾补骨复元汤结合球囊扩张椎体后凸成形术对老年骨质疏松性胸腰椎骨折不愈合患者VAS、骨代谢指标的影响[J]. 中国老年学杂志, 2022,42(9):2150-2153. |
/
| 〈 |
|
〉 |